Meet ProJect Pharmaceutics at 15th World ADC London 2025 Read More » December 2, 2024 ProJect Pharmaceutics’ announces extension of service offering: In-use stability studies Read More » May 6, 2024 ProJect Pharmaceutics receives CIR application renewal (Research Tax Credit) for the benefit of its French customers towards 2025 Read More » January 15, 2024 ProJect Pharmaceutics was granted a US patent on a novel liquid formulation of Bendamustine Read More » October 25, 2023 ProJect Pharmaceutics’ announces new service offering: Excipient quantification Read More » June 5, 2023 Follow us on LinkedIn Read More » November 18, 2022 ProJect Pharmaceutics’ announces new service offering: Determination of the molar protein extinction coefficient according to ICHQ6 Read More » May 10, 2022 FDA approval of a client’s small molecule drug product for i.v. injection Read More » August 3, 2021 ProJect Pharmaceutics receives CIR application (Research Tax Credit) for the benefit of its French customers Read More » July 30, 2021 Business Continuity Statement in the course of the global SARS-CoV-2 pandemic Read More » March 26, 2020 Meet ProJect Pharmaceutics at CPhI 2019 Read More » October 30, 2019 Join ProJect Pharmaceutics at Gene and Cell Therapy_Quality Developments to Commercialization Summit 2019 Read More » June 1, 2019 Page1 Page2 Page3
ProJect Pharmaceutics’ announces extension of service offering: In-use stability studies Read More » May 6, 2024
ProJect Pharmaceutics receives CIR application renewal (Research Tax Credit) for the benefit of its French customers towards 2025 Read More » January 15, 2024
ProJect Pharmaceutics was granted a US patent on a novel liquid formulation of Bendamustine Read More » October 25, 2023
ProJect Pharmaceutics’ announces new service offering: Excipient quantification Read More » June 5, 2023
ProJect Pharmaceutics’ announces new service offering: Determination of the molar protein extinction coefficient according to ICHQ6 Read More » May 10, 2022
ProJect Pharmaceutics receives CIR application (Research Tax Credit) for the benefit of its French customers Read More » July 30, 2021
Business Continuity Statement in the course of the global SARS-CoV-2 pandemic Read More » March 26, 2020
Join ProJect Pharmaceutics at Gene and Cell Therapy_Quality Developments to Commercialization Summit 2019 Read More » June 1, 2019
